FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program

Shenda Hou, Rachel L. Clement, Alos Diallo, Bruce R. Blazar, Alexander Y. Rudensky, Arlene H. Sharpe, Peter T. Sage

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Follicular regulatory T (Tfr) cells are a regulatory T cell subset that controls antibody production by inhibiting T follicular helper (Tfh)–mediated help to B cells. Tfh and Tfr cells possess opposing functions suggesting unique programming. Here we elucidated the transcriptional program controlling Tfr suppressive function. We found that Tfr cells have a program for suppressive function fine-tuned by tissue microenvironment. The transcription factor FoxP3 and chromatin-modifying enzyme EZH2 are essential for this transcriptional program but regulate the program in distinct ways. FoxP3 modifies the Tfh program to induce a Tfr-like functional state, demonstrating that Tfr cells coopt the Tfh program for suppression. Importantly, we identified a Tfr cell population that loses the Tfr program to become “ex-Tfr” cells with altered functionality. These dysfunctional ex-Tfr cells may have roles in modulating pathogenic antibody responses. Taken together, our studies reveal mechanisms controlling the Tfr transcriptional program and how failure of these mechanisms leads to dysfunctional Tfr cells.

Original languageEnglish (US)
Pages (from-to)605-620
Number of pages16
JournalJournal of Experimental Medicine
Volume216
Issue number3
DOIs
StatePublished - Mar 1 2019

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Fingerprint Dive into the research topics of 'FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program'. Together they form a unique fingerprint.

  • Cite this

    Hou, S., Clement, R. L., Diallo, A., Blazar, B. R., Rudensky, A. Y., Sharpe, A. H., & Sage, P. T. (2019). FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program. Journal of Experimental Medicine, 216(3), 605-620. https://doi.org/10.1084/jem.20181134